Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment ofClostridium difficileInfection in Canada

Canadian Journal of Infectious Diseases and Medical Microbiology - Egypt
doi 10.1155/2014/793532
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Economic Evaluation of Fidaxomicin Compared With Vancomycin in the Treatment of Clostridium Difficile Infection

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Hospital Ward Antibiotic Prescribing and the Risks ofClostridium difficileInfection

JAMA Internal Medicine
Internal Medicine
2015English

Prevention ofClostridium difficileInfection withSaccharomyces Boulardii: A Systematic Review

Canadian Journal of Gastroenterology
2009English

Pin8 - Comparative Efficacy of Fidaxomicin, Vancomycin and Metronidazole for the Treatment of Clostridium Difficile Infection: A Network Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical and Economic Consequences of Dyspepsia in the Community

Gut
Gastroenterology
2002English

Cost-Effectiveness Analysis Evaluating Fidaxomicin Versus Oral Vancomycin for the Treatment of Clostridium Difficile Infection in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Fidaxomicin Use and Clinical Outcomes for Clostridium Difficile–Associated Diarrhea

Infectious Diseases in Clinical Practice
Infectious DiseasesMicrobiology
2015English

Systematic Review With Meta-Analysis: The Impact ofClostridium Difficileinfection on the Short- And Long-Term Risks of Colectomy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Short-Term Clinical and Economic Consequences of Coronary Stent Thrombosis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy